Ikarian Capital, LLC Inmune Bio, Inc. Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.97 - $20.38 $265,521 - $542,760	-26,632 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.13 - $27.85 $1.7 Million - $3.35 Million	-120,251 Reduced 81.87%	26,632 $517,000
Q2 2021 Aug 16, 2021	SELL	$9.29 - $19.33 $805,377 - $1.68 Million	-86,693 Reduced 37.12%	146,883 $2.58 Million
Q1 2021 May 17, 2021	BUY	$11.61 - $26.85 $185,852 - $429,814	16,008 Added 7.36%	233,576 $2.78 Million
Q4 2020 Feb 12, 2021	BUY	$7.51 - $17.22 $1.63 Million - $3.75 Million	217,568 New	217,568 $3.75 Million

2.88M

44.6K

3.5K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $145M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.